08/24/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 8/24/2020. This web page offers operational considerations and guidance for maintaining essential HIV services in low-resource settings in the context of COVID-19. (Text)
08/24/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention (CDC). Published: 8/24/2020. Speakers in this 48-minute presentation share updates on the CDC’s COVID-19 response, including the latest scientific information and what everyone should know about protecting themselves and others; and review the CDC’s updated considerations for election polling locations and voters. (Video or Multimedia)
08/21/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 8/21/2020. The CDC offers these considerations, updated on August 21, 2020, for ways in which schools can help protect students, teachers, administrators, and staff and slow the spread of COVID-19. Schools can determine, in collaboration with state and local health officials to the extent possible, whether and how to implement these considerations while adjusting to meet the unique needs and circumstances of the local community. (Text)
08/21/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 8/21/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Texas Department of State Health Services (DSHS) SARS-CoV-2 Assay that has been issued an Emergency Use Authorization (EUA) by FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
08/21/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 8/21/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the DxTerity SARS-CoV-2 RT-PCR Test. he DxTerity SARS-CoV-2 RT-PCR Test is authorized for use with saliva specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
08/21/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 8/21/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Guardant-19 test that has been issued an Emergency Use Authorization (EUA) by FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
08/21/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 8/21/2020. This web page details the CDC’s COVID-19 Response Health Equity Strategy, which broadly seeks to improve the health outcomes of populations disproportionately affected by the COVID-19 pandemic. The population health impact of COVID-19 has exposed long-standing inequities that have systematically undermined the physical, social, economic, and emotional health of racial and ethnic minority populations and other population groups that are bearing a disproportionate burden of COVID-19. (Text)
08/17/2020 12:00 AM EDT
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 8/17/2020. This three-page document from TRACIE (Technical Resources, Assistance Center, and Information Exchange) provides resources in response to a requestor who asked if their healthcare facility needed to change their current terminology from “pandemic/ epidemic” to “emerging infectious diseases” (EID) in their Hazard Vulnerability Assessment (HVA) per the Centers for Medicare & Medicaid Services (CMS) Emergency Preparedness (EP) Rule. (PDF)
08/11/2020 12:00 AM EDT
Source: National Highway Traffic Safety Administration, Office of Emergency Medical Services (EMS). Published: 8/11/2020. This three-page document provides a brief overview of how the coronavirus disease 2019 (COVID-19) impacts trauma triage for first responders, including Emergency Medical Service (EMS), fire and rescue, and law enforcement. (PDF)
08/01/2020 12:00 AM EDT
Source: National Institute for Occupational Safety and Health [Centers for Disease Control and Prevention] (CDC NIOSH). Published: 8/2020. This eight-page report summarizes the filtration performance results from the assessments that took place as a result of the initial Emergency Use Authorization (EUA) issued by the Food and Drug Administration (FDA), and discusses important considerations when purchasing non-NIOSH approved international respiratory devices temporarily authorized for occupational use in the United States. (PDF)
08/01/2020 12:00 AM EDT
Source: Humanitarian Outcomes. Published: 8/2020. This 22-page annual Aid Worker Security Report focuses on humanitarians working in the health sector. It examines the data from 2019 on attacks against health workers, and discusses how the humanitarian sector is dealing with the new risks and disruptions caused by major epidemics occurring in contexts of broader complex emergency. (PDF)
08/01/2020 12:00 AM EDT
Source: Fordham University . Published: 8/2020. The Coronavirus Victimization Distress Scale (CVDS) is a brief self-report questionnaire developed by Fordham University's Center for Ethics Education and Applied Developmental Psychology Program as part of the Pathways to Health Study. The CVDS assesses bully and cyberbully victimization distress results from being viewed as having coronavirus. Questions include distress about being verbally and physically bullied, treated rudely or unfairly, verbally taunted in public, and cyberbullied because of coronavirus. Population: Adults and Teens Ethnic/Religious Groups Sexual or Gender Minorities Length: 5 items Time to Complete: Less than 5 minutes Mode of Administration: Online (e.g., computer-assisted interview) Administered by: Self Administered Language(s): English (PDF)
08/01/2020 12:00 AM EDT
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 8/2020. This 12-page issue of The Exchange from TRACIE (Technical Resources, Assistance Center, and Information Exchange) provides articles that highlight lessons learned (from the responder, practitioner, and planner perspectives) specific to COVID-19 patient surge; patient, caregiver, and provider behavioral health; operational considerations; and telehealth. (PDF)
08/01/2020 12:00 AM EDT
Source: National Academies Press (NAP). Published: 8/2020. This 11-page report is intended to help decision-makers in local public health departments and local governments increase participation and cooperation in contact tracing related to COVID-19. It focuses on contact tracing methods that involve phone, text, or email interviews with people who have tested positive and with others they may have exposed to the virus. (Text)
07/24/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 7/24/2020. This web page discusses how long-standing systemic health and social inequities have put many people from racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19. Topics include factors that contribute to increased risk, what we can do, and data on COVID-19 and race and ethnicity. (Text)
05/21/2020 12:00 AM EDT
Source: Harvard University, Harvard T.H. Chan School of Public Health. Published: 5/21/2020. This is a self-report, online-based questionnaire designed for use with seropositivity testing and administered via Qualtrics to assess exposure to COVID-19 and modifying factors, such as mask usage, in: (1) the residence and household; (2) while taking transportation; and (3) through work and employment. Modules included in survey: I. Introduction. The first section includes three questions related to concerns about exposure to COVID-19 in the home, while using typical forms of transportation, and in the workplace (questions 2 through 4). II. About You. This second section includes up to 13 questions on demographic factors and the survey-taker's experience with COVID-19 testing (questions 6 through 18). III. Residence and Household. This third section includes up to 14 questions about the type and size of the residence, number and ages of other household members, and COVID-19 infection histories of the other household members (questions 20 through 33). IV. Transportation. This fourth section includes up to seven questions about the frequency of activities outside of the home (work/employment, outdoor exercise and recreation, essential errands, and personal and social activities), and the type of transportation used for those activities. If the survey-taker reports use of public transportation, they are asked about mask usage and social distancing while on public transportation (questions 35 through 41). V. Work and Employment (General). This section includes up to four questions about occupation, industry, and work for pay since the beginning of the COVID-19 pandemic (questions 43 through 46). VI. Work and Employment (Work Outside the Home). This section includes up to 13 questions focusing on work outside the home. In particular, survey-takers are asked about hours worked per week, the percent of remote work performed, contact with the public, contact with co-workers, PPE usage, and employer COVID-19 policies (questions 47 through 59). Population: Adults only Length: 59 questions Time to Complete: 15-30 minutes Mode of Administration: Online (e.g., computer-assisted interview) Administered by: Self Administered Language(s): English Questions Adapted From: Q11, Q23, Q46 - American Community Survey; Q9, Q10, Q12, Q13, Q24, Q43, Q44 - U.S. Census Bureau 2020 COVID-19 Household Pulse Survey; Q7, Q8, Q18, Q25 - John Hopkins University COVID-19 Community Response Survey (PDF)
.png)
No hay comentarios:
Publicar un comentario